莫西沙星治疗非淋菌性尿道炎(宫颈炎)52例疗效观察

Observation on clinical efficacy of moxifloxacin on treating 52 cases of non-gonoccocal urethritis(cervicitis)

目的对照观察莫西沙星与阿奇霉素治疗非淋菌性尿道炎（宫颈炎）的疗效。方法对确诊非淋菌性尿道炎（宫颈炎）患者，采取口服拜复乐400mg，1日1次．疗程12d；同时将2003-2005年间服用阿奇霉素治疗组作为对照。结果莫西沙星组治愈率75．0％，总有效率94．2％；阿奇霉素组治愈率62．5％，总有效率为75．0％，两组比较有显著性差异（P〈0．05）；结论莫西沙星疗效明显优于阿奇霉素。可以作为治疗非淋菌性尿道炎（宫颈炎）的有效药物。

OBJECTIVE Controlled observation between moxifloxacin and azithromycin treatment of non- gonococcal urethritis （cervicitis） patients. METHODS The diagnosis of non-gonococcal urethritis （cervicitis） patients take oral moxifloxacin 400mg, once per day, for 12 days; while taking azithromycin treatment as a control group between 2003 - 2005. RESULTS The cure rate of moxifloxacin group was 75.0 %, with the total efficiency of 94.2 % ; while azithromycin group was 62.5 %, with the total efficiency of 75.0 %. There was a significant difference between the two （P 〈 0.05）. CONCLUSION Moxifloxacin is superior to azithromycin, and can be used as the primary drug of choice for the treatment of non-gonococcal urethritis （cervicitis）.